These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 2615046

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease.
    Fisher A, Brandeis R, Karton I, Pittel Z, Gurwitz D, Haring R, Sapir M, Levy A, Heldman E.
    J Pharmacol Exp Ther; 1991 Apr; 257(1):392-403. PubMed ID: 2019998
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Amelioration of experimental amnesia (passive avoidance failure) in rodents by the selective M1 agonist AF102B.
    Nakahara N, Iga Y, Mizobe F, Kawanishi G.
    Jpn J Pharmacol; 1988 Dec; 48(4):502-6. PubMed ID: 3244205
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Impairment of spatial working memory of rats in radial maze performance induced by ethylcholine mustard aziridinium picrylsulfonate (AF64A-P): retention curve analysis.
    Inagawa K.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Feb; 14(1):9-17. PubMed ID: 8048282
    [Abstract] [Full Text] [Related]

  • 7. Effects of a novel cholinergic M1 agonist, AF102B, on ambulation and water drinking behavior in rats.
    Togashi H, Matsumoto M, Yoshioka M, Saito Y, Saito H.
    Hokkaido Igaku Zasshi; 1991 Jan; 66(1):59-66. PubMed ID: 2004736
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dose- and delay-dependent working/episodic memory impairments following intraventricular administration of ethylcholine aziridinium ion (AF64A).
    Chrobak JJ, Walsh TJ.
    Behav Neural Biol; 1991 Sep; 56(2):200-12. PubMed ID: 1759941
    [Abstract] [Full Text] [Related]

  • 13. Central muscarinic activities of an M1-selective agonist: preferential effect on reversal of amnesia.
    Nakahara N, Fujise N, Kawanishi G, Mizobe F.
    Brain Res; 1990 Jan 15; 507(1):172-5. PubMed ID: 2302575
    [Abstract] [Full Text] [Related]

  • 14. AF64A (ethylcholine mustard aziridinium) impairs acquisition and performance of a spatial, but not a cued water maze task: relation to cholinergic hypofunction.
    Opello KD, Stackman RW, Ackerman S, Walsh TJ.
    Physiol Behav; 1993 Dec 15; 54(6):1227-33. PubMed ID: 7507594
    [Abstract] [Full Text] [Related]

  • 15. Regional differences in ethylcholine mustard aziridinium ion (AF64A)-induced deficits in presynaptic cholinergic markers for the rat central nervous system.
    Vickroy TW, Watson M, Leventer SM, Roeske WR, Hanin I, Yamamura HI.
    J Pharmacol Exp Ther; 1985 Dec 15; 235(3):577-82. PubMed ID: 3841155
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of repeated administration of (-)-nicotine on AF64A-induced learning and memory impairment in rats.
    Hiramatsu M, Yamatsu T, Kameyama T, Nabeshima T.
    J Neural Transm (Vienna); 2002 Mar 15; 109(3):361-75. PubMed ID: 11956957
    [Abstract] [Full Text] [Related]

  • 18. AF64A lesions of mouse striatum result in ipsilateral rotations to D2 dopamine agonists but contralateral rotations to muscarinic cholinergic agonists.
    Zhou LW, Zhang SP, Connell TA, Weiss B.
    J Pharmacol Exp Ther; 1993 Feb 15; 264(2):824-30. PubMed ID: 8094754
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.